CRAIG R STAPLETON Insider Trading $AVDL AVADEL PHARMACEUTICALS PLC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CRAIG R STAPLETON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CRAIG R STAPLETON. CRAIG R STAPLETON is Director in ABERCROMBIE & FITCH CO /DE/ ($ANF) and Director in FLAMEL TECHNOLOGIES SA ($FLML).
CRAIG R STAPLETON in AVADEL PHARMACEUTICALS PLC
Trading Symbol: AVDLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CRAIG R STAPLETON: Director
Holdings: 378,228 shares
Latest Transaction: Aug 02 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CRAIG R STAPLETON in AVADEL PHARMACEUTICALS PLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 02 2018 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 0.00 | 27,900 | 0 | 378,228 | 350.3 K to 378.2 K (+7.96 %) |
Jul 11 2018 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 0.00 | 57,315 | 0 | 350,328 | 293 K to 350.3 K (+19.56 %) |
Dec 19 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 8.67 | 70,000 | 606,970 | 180,000 | 110 K to 180 K (+63.64 %) |
Dec 19 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 8.67 | 70,000 | 606,970 | 323,413 | 253.4 K to 323.4 K (+27.62 %) |
Nov 29 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Sell | S | 9.35 | 254,265 | 2,377,632 | 253,413 | 507.7 K to 253.4 K (-50.08 %) |
Sep 14 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Buy | P | 9.52 | 20,000 | 190,360 | 110,000 | 90 K to 110 K (+22.22 %) |
Jun 30 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Option Exercise | A | 10.51 | 30,000 | 315,300 | 30,000 | |
May 22 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Buy | P | 9.76 | 16,900 | 164,944 | 90,000 | 73.1 K to 90 K (+23.12 %) |
May 22 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Buy | P | 9.83 | 3,100 | 30,473 | 73,100 | 70 K to 73.1 K (+4.43 %) |
May 22 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Buy | P | 9.98 | 11,013 | 109,910 | 70,000 | 59 K to 70 K (+18.67 %) |
May 18 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 9.95 | 12,100 | 120,393 | 58,987 | 46.9 K to 59 K (+25.81 %) |
May 18 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 10.00 | 3,470 | 34,700 | 46,887 | 43.4 K to 46.9 K (+7.99 %) |
May 16 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 10.00 | 311 | 3,110 | 43,417 | 43.1 K to 43.4 K (+0.72 %) |
May 16 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 10.00 | 3,106 | 31,060 | 43,106 | 40 K to 43.1 K (+7.77 %) |
Apr 05 2017 | AVDL | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 9.58 | 15,000 | 143,643 | 507,678 | 492.7 K to 507.7 K (+3.04 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Option Exercise | A | 14.54 | 117,449 | 1,707,708 | 117,449 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Option Exercise | A | 14.54 | 100,000 | 1,454,000 | 100,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 0.00 | 16,200 | 0 | 16,200 | 0 to 16.2 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 0.00 | 492,678 | 0 | 492,678 | 0 to 492.7 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Option Exercise | D | 14.54 | 117,449 | 1,707,708 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Option Exercise | D | 14.54 | 100,000 | 1,454,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Sell | D | 0.00 | 16,200 | 0 | 0 | 16.2 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Sell | D | 0.00 | 40,000 | 0 | 0 | 40 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Sell | D | 0.00 | 492,678 | 0 | 0 | 492.7 K to 0 (-100.00 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 16,200 | 0 | 16,200 | 0 to 16.2 K |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 13,500 | 0 | 40,000 | 26.5 K to 40 K (+50.94 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 8,100 | 0 | 26,500 | 34.6 K to 26.5 K (-23.41 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 5,400 | 0 | 34,600 | 40 K to 34.6 K (-13.50 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 13,500 | 0 | 492,678 | 506.2 K to 492.7 K (-2.67 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 8,100 | 0 | 506,178 | 514.3 K to 506.2 K (-1.58 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 5,400 | 0 | 514,278 | 519.7 K to 514.3 K (-1.04 %) |
Nov 30 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 10.85 | 10,000 | 108,500 | 40,000 | 30 K to 40 K (+33.33 %) |
Nov 30 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 10.74 | 10,000 | 107,370 | 30,000 | 20 K to 30 K (+50.00 %) |
Sep 06 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 13.52 | 10,000 | 135,190 | 519,678 | 509.7 K to 519.7 K (+1.96 %) |
Aug 29 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 13.67 | 9,122 | 124,698 | 20,000 | 10.9 K to 20 K (+83.86 %) |
Aug 29 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 13.83 | 10,878 | 150,443 | 10,878 | 0 to 10.9 K |
May 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 9.25 | 2,415 | 22,339 | 509,678 | 507.3 K to 509.7 K (+0.48 %) |
May 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 9.21 | 24,813 | 228,553 | 507,263 | 482.5 K to 507.3 K (+5.14 %) |
Mar 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 10.39 | 100,000 | 1,039,400 | 482,450 | 382.5 K to 482.5 K (+26.15 %) |
Page: 1